Study on diagnosis and treatment of Mycobacterium avium complex pulmonary disease

Not Applicable

• Conditions: Mycobacterium avium complex pulmonary disease

• Registration Number: JPRN-UMIN000045542
• Lead Sponsor: ational Hospital Organization Osaka Toneyama Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-09-30
• Study Start: 2021-09-22
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 94

Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients known to be seropositive for human immunodeficiency virus 2)Judged inadequate to participate in the study by their physicians

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1)Relationship between the outcomes of multidrug chemotherapy and long-term survival prognosis 2)Search for useful prognostic predictors

Secondary Outcome Measures

Name	Time	Method
Evaluation as prognostic factors the following: 1) clinical characteristics 2) chest radiographic findings 3) results of sputum smear-culture examinations for acid-fast bacteria, and serobar 4) results of blood examinations (especially serum antibodies against acid-fast bacteria)